P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN ALZHEIMERS AND PICKS DISEASE

被引:39
|
作者
SMITH, CD
GALLENSTEIN, LG
LAYTON, WJ
KRYSCIO, RJ
MARKESBERY, WR
机构
[1] UNIV KENTUCKY,COLL MED,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,COLL MED,CTR MAGNET RESONANCE IMAGING & SPECT,LEXINGTON,KY 40536
[3] UNIV KENTUCKY,COLL MED,DEPT PATHOL,LEXINGTON,KY 40536
[4] UNIV KENTUCKY,COLL MED,DEPT STAT,LEXINGTON,KY 40536
关键词
PHOSPHORUS MAGNETIC RESONANCE SPECTROSCOPY; ALZHEIMERS DISEASE; PICKS DISEASE; PHOSPHOMONOESTERS; PHOSPHODIESTERS;
D O I
10.1016/0197-4580(93)90026-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Previous studies have suggested a defect in phosphorus metabolism in Alzheimer's disease (AD) gray matter. We have studied phosphorus metabolites in both gray and white matter in autopsy specimens of nine subjects with late-stage AD, three with Pick's disease and seven age-matched controls. Phosphorus metabolites sugar phosphate (SU), phosphomonoester (PME), phosphodiester (PD), and inorganic phosphate (PI) were quantified as mole percentages in regional neocortical specimens using nuclear magnetic resonance spectroscopy. Senile plaque (SP) and neurofibrillary tangle (NFT) counts were determined in adjacent cortical sections. In the inferior parietal lobule gray and white matter, mole percentage normalized PME, and PD were significantly greater than control values in both AD and Pick's disease. A significant correlation was found between PD and NFT in AD parietal gray matter. Our data indicates that phosphorus metabolite alterations are present in two cortical degenerative diseases and are not likely to be specific for AD.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [21] FULLY QUANTITATIVE P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN THE EVALUATION OF LIVER-DISEASE
    MEYERHOFF, DJ
    THOMAS, A
    BOSKA, M
    WEINER, MW
    CLINICAL RESEARCH, 1989, 37 (01): : A113 - A113
  • [22] NONINVASIVE P-31 MAGNETIC-RESONANCE SPECTROSCOPY REVEALED MCARDLE DISEASE IN AN ASYMPTOMATIC CHILD
    GRUETTER, R
    KAELIN, P
    BOESCH, C
    MARTIN, E
    WERNER, B
    EUROPEAN JOURNAL OF PEDIATRICS, 1990, 149 (07) : 483 - 486
  • [23] P-31 MAGNETIC-RESONANCE SPECTROSCOPY FOR DIAGNOSING ABNORMAL TESTICULAR FUNCTION
    VANDERGROND, J
    LAVEN, JSE
    LOCK, MTWT
    TEVELDE, ER
    MALI, WPTM
    FERTILITY AND STERILITY, 1991, 56 (06) : 1136 - 1142
  • [24] HEPATIC CHEMOEMBOLISATION STUDIED BY QUANTITATIVE P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    MEYERHOFF, DJ
    KARCZMAR, GS
    VENOOK, AP
    WILKINSON, M
    VALONE, F
    WEINER, MW
    CLINICAL RESEARCH, 1990, 38 (01): : A104 - A104
  • [25] HYPOTONIA OF RICKETS - A SEQUENTIAL STUDY BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    MIZE, CE
    CORBETT, RJT
    UAUY, R
    NUNNALLY, RL
    WILLIAMSON, SB
    PEDIATRIC RESEARCH, 1988, 24 (06) : 713 - 716
  • [26] CEREBRAL INTRACELLULAR PH BY P-31 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY
    PETROFF, OAC
    PRICHARD, JW
    BEHAR, KL
    ALGER, JR
    DENHOLLANDER, JA
    SHULMAN, RG
    NEUROLOGY, 1985, 35 (06) : 781 - 788
  • [27] P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN THE EOSINOPHILIA-MYALGIA-SYNDROME
    CLAUW, DJ
    HEWES, B
    BLANK, CA
    NELSON, M
    KATZ, P
    RAJAN, S
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S114 - S114
  • [28] APPLICATION OF P-31 MAGNETIC-RESONANCE SPECTROSCOPY TO THE STUDY OF ATHLETIC PERFORMANCE
    MCCULLY, KK
    KENT, JA
    CHANCE, B
    SPORTS MEDICINE, 1988, 5 (05) : 312 - 321
  • [29] BRAIN METABOLISM IN HYPOTHYROIDISM STUDIED WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    SMITH, CD
    AIN, KB
    LANCET, 1995, 345 (8950): : 619 - 620
  • [30] P-31 MAGNETIC-RESONANCE SPECTROSCOPY - A NEW RESEARCH INSTRUMENT IN UROLOGY
    POMER, S
    UROLOGE-AUSGABE A, 1989, 28 (04): : 223 - 230